Maxcyte, Inc.
MXCT· Nasdaq
Released Mar 12, 2024, after the close
10-K filed Mar 12, 2024, 72 days after period end · 0001558370-24-003001
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $7.51M | — |
| Net Income | -$5.28M |
Maxcyte, Inc. · CIK 1287098 · Engraved from SEC EDGAR
| -$4.81M |
| -$4.87M |
| -$2.65M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.